Effect of cystamine on blood pressure and vascular characteristics in spontaneously hypertensive rats

Journal of Vascular Research

Volumn 48, Issue 6, 2011, Pages 476-484

  Engholm, M ^a   Eftekhari, A ^a   Chwatko, G ^b   Bald, E ^b   Mulvany, M J ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Cystamine; Hypertension; Remodelling; Spontaneously hypertensive rats; Telemetry; Tissue transglutaminase

Indexed keywords

AMLODIPINE; CYSTAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HEMODYNAMICS; LIQUID CHROMATOGRAPHY; MALE; MESENTERIC ARTERY; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY;

ADAPTATION, PHYSIOLOGICAL; AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CYSTAMINE; ENZYME INHIBITORS; GTP-BINDING PROTEINS; HYPERTENSION; MALE; MESENTERIC ARTERIES; ORGAN CULTURE TECHNIQUES; RATS; RATS, INBRED SHR; TRANSGLUTAMINASES;

EID: 79960489547     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000327773     Document Type: Article

References (31)

1. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ: Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitationcontraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61: 181-186. (Pubitemid 17137117)
2. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; 22: 523-526. (Pubitemid 23292158)
3. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL: Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007; 25: 1021-1026. (Pubitemid 46573121)
4. Rizzoni D, Porteri E, Boari GE, De CC, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E: Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108: 2230-2235. (Pubitemid 37363040)
5. Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, De Mey JG: Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res 2001; 89: 180-186. (Pubitemid 34135827)
6. Bakker EN, van Der Meulen ET, van den Berg BM, Everts V, Spaan JA, VanBavel E: Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 2002; 39: 12-20. (Pubitemid 34158355)
7. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, VanBavel E: Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005; 96: 119-126. (Pubitemid 40095761)
8. Lee KN, Birckbichler PJ, Patterson MK Jr: GTP hydrolysis by guinea pig liver transglutaminase. Biochem Biophys Res Commun 1989; 162: 1370-1375. (Pubitemid 19214734)
9. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrinbinding adhesion coreceptor for fibronectin. J Cell Biol 2000; 148: 825-838.
10. Martinez J, Chalupowicz DG, Roush RK, Sheth A, Barsigian C: Transglutaminasemediated processing of fibronectin by endothelial cell monolayers. Biochemistry 1994; 33: 2538-2545. (Pubitemid 24099661)
11. Lorand L, Graham RM: Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-156. (Pubitemid 36172696)
12. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van RN, Candi E, VanBavel E: Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 2006; 99: 86-92. (Pubitemid 44297059)
13. Pistea A, Bakker EN, Spaan JA, Hardeman MR, van RN, VanBavel E: Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases. J Vasc Res 2008; 45: 10-18. (Pubitemid 350275239)
14. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C, Buus CL, Mulvany MJ: Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res 2007; 44: 471-482. (Pubitemid 350022321)
15. Bakker EN, van Der Meulen ET, Spaan JA, VanBavel E: Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol Heart Circ Physiol 2000; 278:H1233-H1240. (Pubitemid 30235501)
16. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26. (Pubitemid 8132079)
17. Balakrishnan S, McNeill JR: Cardiac output mediates the antihypertensive effect of vasopressin in spontaneous hypertension. Am J Physiol 1996; 271:H1728-H1733.
18. McCarron JG, Quayle JM, Halpern W, Nelson MT: Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries. Am J Physiol 1991; 261:H287-H291.
19. Bald E, Glowacki R: 2-Chloro-1-methylquinolinium tetrafluoroborate as an effective and thiol specific UV-tagging reagent for liquid chromatography. J Liq Chromatogr Relat Technol 2001; 24: 1323-1339. (Pubitemid 32539038)
20. Kusmierek K, Glowacki R, Bald E: Determination of total cysteamine in human plasma in the form of its 2-S-quinolinium derivative by high performance liquid chromatography. Anal Bioanal Chem 2005; 382: 231-233. (Pubitemid 40682903)
21. Adner M, Geary GG, Edvinsson L: Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol Scand 1998; 163: 121-129. (Pubitemid 28270897)
22. Li X, Wei XL, Meng LL, Chi MG, Yan JQ, Ma XY, Jia YS, Liang L, Yan HT, Zheng JQ: Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes. Hypertension 2009; 54: 839-844.
23. Jeitner TM, Delikatny EJ, Ahlqvist J, Capper H, Cooper AJ: Mechanism for the inhibition of transglutaminase 2 by cystamine. Biochem Pharmacol 2005; 69: 961-970. (Pubitemid 40312713)
24. Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM: Redox regulation of transglutaminase 2 activity. J Biol Chem 2010; 285: 25402-25409.
25. Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, Oh YJ, Sikka G, Kuo M, Halushka MK, Macgregor AM, Dunn J, Gutbrod S, Yin D, Shoukas A, Nyhan D, Flavahan NA, Belkin AM, Berkowitz DE: Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res 2010; 107: 117-125.
26. Jeitner TM, Bogdanov MB, Matson WR, Daikhin Y, Yudkoff M, Folk JE, Steinman L, Browne SE, Beal MF, Blass JP, Cooper AJ: N-(γ-L-glutamyl)-L- lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. J Neurochem 2001; 79: 1109-1112. (Pubitemid 33117092)
27. Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJ, Ratan RR, Beal MF, Hersch SM, Ferrante RJ: Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci 2002; 22: 8942-8950. (Pubitemid 35379064)
28. Karpuj MV, Becher MW, Springer JE, Chabas D, Youssef S, Pedotti R, Mitchell D, Steinman L: Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 2002; 8: 143-149. (Pubitemid 34155125)
29. Van Raamsdonk JM, Pearson J, Bailey CD, Rogers DA, Johnson GV, Hayden MR, Leavitt BR: Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. J Neurochem 2005; 95: 210-220. (Pubitemid 41384439)
30. Im MJ, Russell MA, Feng JF: Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal 1997; 9: 477-482. (Pubitemid 27487365)
31. Sharifi AM, Li JS, Endemann D, Schiffrin EL: Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 1998; 16: 457-466. (Pubitemid 28195855)